License Agreements - MacroGenics (Details) - USD ($) $ in Thousands |
1 Months Ended | 12 Months Ended | ||
---|---|---|---|---|
Dec. 31, 2017 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
License agreements | ||||
Research and development | $ 1,458,179 | $ 2,215,942 | $ 1,154,111 | |
MacroGenics | ||||
License agreements | ||||
Research and development | 72,300 | 59,000 | $ 51,100 | |
MacroGenics | Accrued and other liabilities | ||||
License agreements | ||||
Accrued and other liabilities | $ 700 | $ 100 | ||
Minimum | MacroGenics | ||||
License agreements | ||||
Royalty payments on future global net sales (as a percent) | 15.00% | |||
Maximum | MacroGenics | ||||
License agreements | ||||
Royalty payments on future global net sales (as a percent) | 24.00% | |||
Development and Regulatory Milestones | Maximum | MacroGenics | ||||
License agreements | ||||
Additional milestone payments under the license agreement | $ 350,000 | |||
Commercialization Milestones | Maximum | MacroGenics | ||||
License agreements | ||||
Additional milestone payments under the license agreement | $ 330,000 |